ABOUT CONOLIDINE

In the new study, we claimed the identification along with the characterization of a whole new atypical opioid receptor with distinctive detrimental regulatory properties in the direction of opioid peptides.1 Our results showed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is additionally